Western-style diets have been implicated in triggering inflammatory bowel disease activity. The aim of this study was to identify the effect of a short-term diet high in sugar on susceptibility to colitis. Adult wild-type mice were placed on chow or a high sugar diet (50% sucrose) ± acetate. After two days of diet, mice were treated with dextran sodium sulfate (DSS) to induce colitis. Disease severity was assessed daily. Colonic tissues were analyzed for cytokine expression using the MesoScale discovery platform. Intestinal dextran permeability and serum lipopolysaccharide levels (LPS) were measured. Gut microbiota were analyzed by 16s rRNA sequencing and short chain fatty acid (SCFA) concentrations by gas chromatography. Bone marrow-derived macrophages (BMDM) were incubated with LPS and cytokine secretion measured. Mice on a high sugar diet had increased gut permeability, decreased microbial diversity and reduced SCFA. BMDM derived from high sugar fed mice were highly responsive to LPS. High sugar fed mice had increased susceptibility to colitis and pro-inflammatory cytokine concentrations. Oral acetate significantly attenuated colitis in mice by restoring permeability. In conclusion, short term exposure to a high sugar diet increases susceptibility to colitis by reducing short-chain fatty acids and increasing gut permeability.
Inflammatory bowel disease (IBD), and its two subtypes Crohn’s disease and ulcerative colitis are multifactorial in nature, developing due to a complex interplay between genetic, environmental, microbial, and immunologic factors1. Although the importance of diet in the development of IBD remains unclear, dietary factors do appear to play a role in either the triggering of disease flares or modulating disease phenotypes2,3,4. Of interest has been the parallel rise of both a ‘western diet’ (i.e. a diet that is high in fat and refined sugars) worldwide, and a corresponding geographic increase in the incidence of IBD, which continues to grow as a global health problem5,6.
Most experimental findings relating to the ‘western diet’ and IBD have focused on high-fat content alone or in combination with high-sugar; thus the isolated effects of dietary refined sugars on enteric microbial composition, luminal milieu, and susceptibility to colitis are not well understood2. Population-based studies have demonstrated an association between intake of refined sugar and artificial sweeteners and increased incidence of IBD7,8,9,10,11,12. In addition, dietary surveys indicate that ~10% of IBD patients feel that “sugary” foods trigger disease flare-ups and worsen severity of their symptoms13,14. Interestingly, the elevated incidence of IBD associated with a high-sugar diet can be reversed by a diet rich in fiber8. The protective mechanism of dietary fiber is thought to be due in part to the metabolism of carbohydrate polymers into short-chain fatty acids (SCFAs) by specific bacterial populations15. SCFAs, which include butyrate and acetate, are thought to play a role in IBD status which is supported by the fact that depressed levels of SCFAs have been described in the stool of IBD patients16,17,18.
In mouse models of IBD, the resident microbiota has been shown to influence disease severity and outcome and transfer of colitogenic microbial communities has been shown to alter colitis susceptibility in recipients19,20. Changes in gut microbial composition have also been associated with IBD; most notably decreases in the level of Firmicutes and/or Bacteroides and an increase in relative abundance of Proteobacteria have been described in numerous publications21,22. However, whether these alterations in gut microbiota are causal or occur due to the presence of inflammation in the intestine remains to be conclusively demonstrated23.
In this study, we aimed to assess the impact of a short-term dietary exposure to high sugar on colitis susceptibility in order to examine how daily fluctuations in diet may trigger disease flares in susceptible patients. Given the apparent relationship between a high-sugar diet and colitis we hypothesized that a diet high in refined sugar would elicit alterations in gut microbial metabolism and increase disease susceptibility.
Wild-type mice on a 129S1/SvimJ background were raised at the University of Alberta and housed under conventional conditions. At 6–8 weeks of age, female mice were placed on either a chow diet (CH) (LabDiet 5001) or a high sugar diet (HS) (50% Sucrose; Harlan Teklad AIN76A) for a period of two days. Fiber content was 5% (cellulose) and 5.3% (crude fiber) in the HS and chow diets respectively. Mice from the same litter were randomized to separate cages and groups and each experiment was repeated twice. After two days on the different diets, mice were treated with a low concentration of dextran sodium sulfate (DSS 3%; MW 35–45,000 kDa; MP Biomedicals) added to their drinking water (Day 0). After five days, DSS was removed and replaced with regular drinking water. Mice were sacrificed on Day 10 and tissues collected and snap frozen for further study (Fig. 1). Body weight, stool consistency, and fecal occult blood (FOB) were measured daily. FOB positivity was determined using the Hemoccult (Beckman Coulter) test. A disease activity index (DAI) was used that included percentage weight loss, stool consistency, and blood in stool. Each parameter was measured on a scale of 0–4 for a total DAI ranging from 0–12. The weight and length of colon and the weight of the cecum was measured at the time of sacrifice. To determine the role of acetate, a parallel group of mice received acetate (NaAc:300 mM) in the drinking water throughout the experiment beginning at day -2 when the mice were switched to the different diets. All experiments were repeated in cohorts of mice from different litters. Animal use protocols were approved by the animal care committee at the University of Alberta and all experiments were carried out in accordance with the relevant guidelines and regulations.
Colons were flushed with phosphate-buffered saline and immediately fixed in neutral buffered formalin (10%vol:vol). The fixed samples were processed with the use of standard paraffin-embedded histologic methods and hematoxylin and eosin staining. Disease scoring was based on a scoring method that included measurement of epithelial hyperplasia (0–3), enterocyte injury (0–3), and the presence of lymphocytes and neutrophils (0–4) in the lamina propria24. Total histologic score was calculated as the sum of the individual variables and had a maximum score of 10.
Preparation of bone-marrow derived macrophages
Wild-type mice were placed on chow (n = 4) or high sugar diet (n = 4) for two days. At sacrifice, femurs and tibias from each mouse were removed and cleaned, ends of bones snipped and bone marrow flushed with 10 mL of magnesium and calcium free (MCF) phosphate buffered saline (PBS), then pooled for each mouse25. Pooled cells were centrifuged at 1000 rpm for 5 minutes and supernatant removed. The pellet was reconstituted in 2 mL of macrophage complete media. Bone marrow cells were enumerated using a Coulter counter and 2 × 106 cells plated in 10 mL of macrophage complete media (MCM) which included Dulbecco’s modified eagle media (DMEM/F12), 10% heat inactivated fetal bovine serum (FBS), penicillin (100 U/ml), L-glutamine (10 mM), 100 ug/ml streptomycin and 20% macrophage colony-stimulating factor (M-CSF) obtained from L929 cell line. Cells were incubated at 37 °C and 5% CO2 for 7 days. On day 7, cells were washed with warm M-CSF PBS and then scraped and pooled into a 50 mL conical tube. Five mL of cold DMEM/F12-10 media was added to each conical and centrifuged for 10 minutes at 400 g and 4 °C. Cells were counted and 1 × 105 cells plated into each well. Cells ± lipopolysaccharide (LPS;10 /µg/ml) were incubated at 37 °C and 5% CO2 incubator for 24 hours.
Measurement of tissue cytokines
Snap frozen colonic tissue was homogenized in PBS containing 0.05% Tween 20. Homogenates were centrifuged at 9600 × g for 10 minutes. IFN-γ, IL-1β, IL-10, IL-12 p70, IL-2, IL-4, IL-5, KC/GRO (keratinocyte chemoattractant/human growth-regulated oncogene), IL-6, and TNF-α were evaluated using the Proinflammatory Panel 1 V-PLEX Mouse Kit (Meso Scale Discovery, Rockville, MD) as per manufacturer’s protocol. TGF-β was measured using ELISA duo set (R&D Systems, Inc., Minneapolis, MN). Cytokine levels were corrected for tissue weight.
Cecums were collected at sacrifice and immediately snap frozen in liquid nitrogen and stored at −80 °C until processed for either microbial composition or SCFA. Freshly voided stools were collected and frozen. For sequencing, DNA was extracted using AquaStool and cleaned using ethanol precipitation. Microbial composition was assessed using Illumina’s established 16S rRNA amplicon sequencing method and the MiSeq sequencing platform. Briefly, a segment of the V3 and V4 region of the 16S gene was amplified with gene specific primers (aligning to 341 bp and 805 bp in the gene) that also included an adapter sequence overhang: Bact_16s_ILL1_341mF 5-TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN GGC WGC AG-3, Bact_16s_ILL1_805mR 5- GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV GGG TAT CTA ATC C-3. This PCR reaction was cycled 25 times and the resulting reaction purified using bead-based clean-up followed by an 8 cycle PCR reaction using Illumina’s proprietary bar-coding primers that also align to the adapter sequence. After a second clean-up the bar-coded libraries were diluted, denatured, pooled and run using a V3 300 bp reagent cartridge on the MiSeq system. Bacterial composition was estimated using Quantitative Insights into Microbial Ecology (QIIME 1.9.1) pipelines26. QIIME was used to de-multiplex the barcoded reads and perform chimera filtering. Filtered sequence reads were grouped into OTUs at a sequence similarity level of 97%, which approximates species-level phylotypes. Taxonomy of the OTUs was assigned and sequences were aligned with RDP classifier and Pynast27. Alpha diversities of each microbial community were calculated using the Shannon diversity metric.
Assessment of gut permeability
At sacrifice, a 10 cm portion of small intestine was excised distally from 10 cm below the ligament of Treitz and flushed with ice-cold phosphate-buffered saline (PBS). The intestinal segment was ligated at one end and a tube was inserted to add 400 µl of fluorescein isothiocyanate (FITC)/rhodamine dextran (40 µg/mL FITC-labelled 4 kDa dextran, and 40 µg/mL rhodamine labelled 70 kDa dextran in Hank’s Buffered Salt Solution). A ligature was applied as the tube was removed. The length and width of the segment was measured and then submerged in 10 mL of HBSS maintained at 37 °C and percolated with carbogen (95% O2, 5% CO2). Samples (100 µl) were collected from surrounding media at baseline and every ten minutes for thirty minutes. Fluorescence was measured using a SpectraMax M3 spectrophotometer (Molecular Devices, USA) fluorescence at 438ex/544em for FITC and once at 520ex/590em for rhodamine. A leakage ratio was calculated for each time point by normalizing dextran (µg) to the gut volume then dividing the 4 kDa dextran by 70 kDa dextran to obtain a ratio. Serum LPS measurement was carried out using the Pyrochrome Limulus Amoebocyte Lysate (LAL) assay according to manufacturer’s instructions (Associates of Cape Cod Incorporated).
Measurements of short-chain fatty acids (SCFA)
The concentrations of SCFA in cecal contents were determined using gas chromatography. Stool (0.2 g) was homogenized in 800 uL of 0.1 N hydrochloric acid. Phosphoric acid (200 µl of 25%) was then added and the sample centrifiuged at 3 000 × g for ten minutes. Supernatant was added to internal standard solution (150 mg of 4-methyl-valeric acid, S381810, Sigma-Aldrich) and 5% phosphoric acid in a glass chromatography tube, mixed well, and kept at room temperature for 30 min. The supernatant was analyzed for SCFA using a Varian model 3400 Gas Chromatograph (Varian, Walnut Creek, CA) with a Stabilwax-DA column (30-m × 0.25-mm i.d.; Restek, Bellefonte, PA). A flame-ionization detector was used with an injector temperature of 170 °C and a detector temperature of 190 °C.
All data is presented as the mean ± SEM. Statistical analysis was performed using STATA v13.1. Differences between group means were evaluated by using one-way analysis of variance with Tukey post hoc test to correct for multiple comparisons. White’s nonparametric t-test was used to compare microbial communities between groups, with Benjamini-Hochberg test applied to assess for false discovery rate. Principal component analysis (PCA) plots of bacterial populations were created using Metaboanalyst 3.0. Significance was defined as p < 0.05.
High-sugar diet impairs barrier function and enhances susceptibility to DSS-induced colitis
Mice on a high sugar diet (HS; n = 5) for two days had no changes in weight, caloric consumption, or general activity level compared with mice which remained on chow diet (data not shown). There were also no changes seen in colonic tissue levels of IL-1β (Fig. 2A), IL-6 (Fig. 2B), IL-10 (Fig. 2C), or TNFα (Fig. 2D). However, a HS diet did lead to a significant depression in the colonic concentration of IL-12p70 (Fig. 2E) and the neutrophil chemoattractant, KC/GRO (Fig. 2F). Mice on the HS diet also demonstrated a significant increase in gut permeability as assessed directly in intestinal loops (Fig. 2G) (p < 0.01) and indirectly by increased levels of LPS in the serum (Fig. 2H) (p < 0.05). There were no differences in levels of IL-2, IL-4, IL-5, IFNγ or TGFβ (data not shown). To determine if consuming a HS diet over two days altered disease susceptibility, mice were given dextran sodium sulfate (DSS). As seen in Fig. 3A, HS fed mice had an increased severity of disease by Day 5 and upon removal of DSS, failed to recover while chow fed mice showed a complete recovery (Fig. 3A). Further physical evidence of increased colitis was manifested as a shortened colon in the HS fed mice at the time of sacrifice (Table 1). Histological analysis showed an increased total histological injury in HS fed mice (Fig. 3C), increased epithelial damage (Fig. 3D) and increased lymphocytic and neutrophilic infiltration into the lamina propria (Fig. 3E). Representative histological images of effects of DSS treatment in chow and HS-fed mice are shown in Fig. 3F,G respectively. Increased severity of colitis was also evidenced by increased tissue levels of IL-1β (Fig. 4A) and TNFα (Fig. 4B) (p < 0.05) following DSS administration. There were no significant changes in IL-6 (Fig. 4C), KC/GRO (Fig. 4D), IL-12p70 (Fig. 4E), IL-10 (Fig. 4F) or IFNγ (Fig. 4G).
High- sugar diet induces changes in bone-marrow derived monocytes (BMDM)
The DSS model is characterized by damage to enterocytes and invasion of luminal bacteria; this then induces a massive infiltration of neutrophils and blood monocytes into the lamina propria which both amplify and then effectively resolve inflammation28. A systemic priming of blood monocytes by cytokines or other factors can effectively result in heighted pro-inflammatory cytokine responses by monocytes to bacteria products and an exacerbation of inflammation29. In that HS-fed mice showed increased severity and lack of resolution of inflammation, we examined bone-marrow derived monocytes to determine the responsiveness of these systemic immune cells to bacterial products following 2 days on the HS diet. BMDMs derived from HS fed mice exhibited enhanced basal secretion of IL-12p70 (Fig. 5A) and TNFα (Fig. 5C) compared to BMDMs from chow fed mice. There was no difference in basal IL-1β (Fig. 5B) or IL-10 (Fig. 5E) secretion between the two groups. When treated with LPS, all BMDMs increased secretion of IL-1β (Fig. 5B), TNFα (Fig. 5C) and IL-10 (Fig. 5E). BMDMs from HS fed mice released significantly more TNFα when stimulated with LPS compared with BMDM from chow-fed mice (Fig. 5D).
High-sugar diet leads to rapid microbial dysbiosis
In that alterations in gut microbial composition have been linked with increased susceptibility to colitis30, we analyzed microbiota in stools and cecal contents prior to and following the diet switch. Figure 6A shows stools taken from individual mice prior to and following two days on a HS or chow diet. Stools taken from mice prior to diet change clustered together. Mice remaining on the chow diet for 2 days also clustered with the baseline samples. However, stools from mice that switched to the HS diet clustered apart and separately from the baseline samples. Figure 6B shows that cecum samples from chow and HS-fed mice also clustered apart. Complete microbial profiles are shown in Supplementary Fig. 1 and relative abundance values in Supplementary Table 1. At the phyla level, Verrucomicrobia was found to be elevated in HS fed mice (p < 0.01, FDR < 0.01), while Firmicutes and Tenericutes were depleted (p = 0.02, FDR < 0.04) (Fig. 7A). At the family level, Lachnospiraceae, Anaeroplasmataceae and Prevotellaceae were significantly decreased by a HS diet (p < 0.01, FDR < 0.02) while Verrucomicrobiaceae and Porphyromonadaceae were significantly elevated (p < 0.01, FDR < 0.02) (Fig. 7B). HS fed mice also demonstrated an overall loss of α-diversity compared to chow-fed mice as measured by the Shannon index (Chow: 6.5 ± 0.4; HS: 5.1 ± 0.3; p < 0.02).
Acetate partially reversed the enhanced susceptibility to colitis induced by a high-sugar diet
The microbial changes induced by two days on a HS diet were associated with significant changes in SCFA concentrations in the cecum. In particular, acetate was found to be significantly depleted in cecal contents compared to chow fed mice (p < 0.05) (Fig. 8A). There were no significant changes in levels of cecal propionate (Fig. 8B) or butyrate (Fig. 8C). Total levels of cecal SCFA were also reduced in the HS fed mice (Fig. 8D) (p < 0.05). Given the significant reduction in cecal levels of acetate following two days of a HS diet, we hypothesized that a loss of luminal acetate was critical in enhancing disease susceptibility. To test this hypothesis, we supplemented mice with acetate in the drinking water prior to DSS. There was no significant difference in drinking water consumption between acetate-treated and nontreated mice (data not shown). The addition of acetate modulated the inflammatory milieu of the colon prior to the introduction of DSS in HS-fed mice, significantly increasing the concentrations of IL-6 (Fig. 2B), IL-10 (Fig. 2C), and IL-12p70 (Fig. 2E). Chow fed mice receiving acetate showed a significant increase in KC/GRO levels compared with chow fed alone (Fig. 2F). Acetate increased the concentration of IL-12p70 to a greater extent than IL-10 compared to the baseline values seen in HS fed mice (Elevation of IL-12: 463% (108), Elevation of IL-10: 111% (25) p < 0.03). In addition, acetate prevented the increase in intestinal permeability seen in the HS fed mice (Fig. 2G) and reduced levels of serum LPS (Fig. 2H). Compared with mice on the HS diet, mice on the HS diet supplemented with acetate had decreased severity of DSS-induced colitis and enhanced repair as evidenced by reduced DAI (Fig. 3B), reduced total histological score (Fig. 3C), reduced epithelial damage (Fig. 3E) and increased colon length (Table 1).
Acetate did not alter intestinal microbial composition
The addition of acetate to the drinking water of mice had no significant effect on microbial community composition in either stool (Chow: Fig. 6C; HS: Fig. 6D) or cecum (Fig. 6B) of chow and HS fed mice. (Supplementary Fig. 1). Interestingly, while supplementation of chow-fed mice with acetate did significantly elevate the level of acetate in the cecum (Fig. 8A), this was not mirrored in the HS fed group. Levels of cecal propionate or butyrate were not altered by either diet or acetate supplementation (Fig. 8).
In this study we demonstrate that a two-day exposure to a high-sugar diet rapidly alters gut microbial composition, depletes short chain fatty acids and increases susceptibility to chemically induced colitis. This effect was significantly attenuated through the supplementation of acetate independently of changes in microbial community composition. These findings are consistent with recent literature purporting the risks of a high-sugar diet in the triggering and perpetuation of inflammatory bowel diseases and the protective role of SCFA8,15,31.
The dramatic effect of just two days of a high-sugar diet on microbial function and populations may shed light on the role of diet in triggering disease flares in patients with inflammatory bowel disease. An especially meaningful change in this study included the loss of important SCFA producing microbes belonging to the Lachnospiraceae family. This family is capable of producing numerous SCFAs, including butyrate and acetate32. A high sugar diet was also associated with an overall decrease in microbial α-diversity compared to chow diet. Community diversity and the interactions between different microbes are crucial in the production of SCFAs33,34. Therefore, the loss of individual microbial groups important in the creation of SCFAs, alongside a loss in overall community α-diversity, may be responsible for the decline in luminal SCFAs seen in a high-sugar diet. Interestingly, some artificial sweeteners have also been shown to alter gut microbiota and influence host physiological responses35,36,37. A study by Suez et al.36 showed that consumption of saccharin for 5 days in healthy human volunteers resulted in decreased glycemic responses that correlated with alterations in gut microbiota. In an animal model of CD-like ileitis, a 6-week intake of Splenda (sucralose maltodextrin) caused a bloom of Proteobacteria and gut dysbiosis with increased evidence of local gut inflammation37. It remains to be shown however, if short-term intake of sweeteners also increases susceptibility to colitis.
The loss of intestinal barrier function in the mice fed the high sugar diet could have been due to either a direct effect of high levels of luminal sucrose or alternatively linked with a decrease in SCFA production. SCFA, including acetate, propionate, and butyrate, are produced by gut microbial fermentation along the entire intestinal tract including the small intestine38,39. SCFA regulate gut immune and barrier function, as well as having a role in epithelial cell proliferation, differentiation, and apoptosis. SCFA also promote nutrient absorption, lipid metabolism, mucin production, and expression of antimicrobial peptides31. The importance of acetate in gut health was reinforced by the improvement in colitis susceptibility following the supplementation of acetate. Acetate did not elicit any significant changes in bacterial community composition or increase levels of butyrate but was able to independently enhance the ability of high sugar fed mice to recover from an intestinal chemical insult. Several studies have previously shown that luminal acetate induces protective barrier effects in the intestine both directly through effects on epithelial cells and indirectly through effects on immune cells40,41,42. In addition, oral acetate has previously been shown to reduce severity of DSS colitis when given prior to DSS43,44. In our study, the loss of small intestinal barrier function that occurred during high sugar feeding was prevented by the provision of acetate in the drinking water. This would suggest that the increased gut permeability was not occurring due to high levels of luminal glucose, but rather a lack of SCFA production. Interestingly the provision of oral acetate did not result in an increase in levels of cecal acetate in the mice fed the high sugar diet. However, acetate is both absorbed in the small intestine and used as cross feeding by many microbial species; thus, a lack of increase in the cecum was likely due to utilization in the upper gut.
In addition to increases in gut permeability prior to DSS treatment, high sugar fed mice also exhibited decreased colonic tissue levels of IL12p70 and KC-GRO suggesting dietary-induced changes in innate immune function in the colon. In contrast, following DSS, enhanced tissue levels of TNFα and IL-1β were seen in the high sugar fed mice. Interactions and crosstalk between resident intestinal macrophages, T cells, dendritic cells, epithelial cells and innate lymphoid cells are important in maintaining tissue homeostasis and in coordinating responses to injury. The DSS model of colitis is characterized by damage to enterocytes and invasion of luminal bacteria followed by an influx of neutrophils and blood monocytes from the systemic circulation into the lamina propria29. This influx of blood monocytes is critical both for the initial response to bacterial invasion and for the resolution of tissue damage. Depletion of monocytes has been shown to reduce disease severity in acute models of inflammation, including in the DSS model, indicating their importance in the pathophysiology of acute inflammation45. The reduced colonic tissue levels of IL12-p70 and KC-GRO prior to DSS treatment indicated dietary-induced localized effects on colonic immune function. In order to determine if consuming a diet high in sugar had systemic as well as localized effects on immune function, we examined the phenotype of isolated bone-marrow derived monocytes (BMDM) from high sugar fed mice before treatment with DSS. An interesting finding in this study was that BMDM from high sugar fed mice were more responsive to inflammatory stimuli compared to BMDM from chow fed mice and produced higher amounts of TNFα and IL-12p70 under basal conditions. It is possible that this altered phenotype of BMDM occurred due to the increased levels of LPS in the serum of high sugar mice as previous studies have suggested that exposure of blood monocytes to signals in the systemic circulation such as inflammatory cytokines or LPS can result in monocytes that are primed to release higher levels of pro-inflammatory cytokines29. TNFα and IL-12p70 are key markers of an inflammatory or M1 macrophage phenotype46,47, suggesting that BMDM from the high sugar fed mice were already primed and differentiated towards an inflammatory M1 phenotype prior to their influx into the lamina propria. This influx of enhanced inflammatory monocytes likely contributed to the increased tissue levels of TNFα and IL-1β seen in the high sugar fed mice and contributed to the increased severity of inflammation.
In conclusion, this paper provides mechanistic insight into the epidemiologic findings implicating a high-sugar diet in the triggering and perpetuation of inflammation in patients with inflammatory bowel disease. The results show that a short-term diet high in sugar results in an enhanced intestinal permeability coupled with a more inflammatory monocyte phenotype that results in an increased susceptibility to colonic insults and a lack of ability to repair damage. The findings that acetate alone substantially alleviates the deleterious effects of a high-sugar diet adds to the body of evidence suggesting that SCFAs play a crucial role in the response of the gut to insults and tissue repair.
Abraham, C. & Cho, J. H. Inflammatory bowel disease. N Engl J Med 361, 2066–2078 (2009).
Lewis, J. D. & Abreu, M. T. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology 152, 398–414 e396 (2017).
Ananthakrishnan, A. N. et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut 63, 776–784 (2014).
Ananthakrishnan, A. N. et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology 145, 970–977 (2013).
Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769–2778 (2018).
Kaplan, G. G. & Ng, S. C. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 152, 313–321 e312 (2017).
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
Racine, A. et al. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis 22, 345–354 (2016).
Qin, X. Etiology of inflammatory bowel disease: a unified hypothesis. World J Gastroenterol 18, 1708–1722 (2012).
Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr 36, 321–347 (2017).
Hansen, T. S. et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 5, 577–584 (2011).
Sakamoto, N. et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11, 154–163 (2005).
Eppinga, H. & Peppelenbosch, M. P. Worsening of Bowel Symptoms Through Diet in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 22, E6–7 (2016).
Limdi, J. K., Aggarwal, D. & McLaughlin, J. T. Diet and Exacerbation of Inflammatory Bowel Disease Symptoms–Food for Thought. Inflamm Bowel Dis 22, E11 (2016).
Macia, L. et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6, 6734 (2015).
Huda-Faujan, N. et al. The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4, 53–58 (2010).
Takahashi, K. et al. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn’s Disease. Digestion 93, 59–65 (2016).
Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275–1283 (2014).
Saleh, M. & Elson, C. O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34, 293–302 (2011).
Roy, U. et al. Distinct Microbial Communities Trigger Colitis Development upon Intestinal Barrier Damage via Innate or Adaptive Immune Cells. Cell Rep 21, 994–1008 (2017).
Frank, D. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS 104, 13780–13785 (2007).
Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
Winter, S. E., Lopez, C. A. & Baumler, A. J. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14, 319–327 (2013).
Madsen, K. et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591 (2001).
Weischenfeldt, J. & Porse, B. Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. CSH Protoc 2008, pdb prot5080 (2008).
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335–336 (2010).
Caporaso, J. G. et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266–267 (2010).
Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104, Unit 15 25 (2014).
Jones, G. R. et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol 9, 2764 (2018).
Brinkman, B. M. et al. Gut microbiota affects sensitivity to acute DSS-induced colitis independently of host genotype. Inflamm Bowel Dis 19, 2560–2567 (2013).
Tan, J. et al. The role of short-chain fatty acids in health and disease. Adv Immunol 121, 91–119 (2014).
Vital, M., Karch, A. & Pieper, D.H. Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data. mSystems 2 (2017).
De Vuyst, L. & Leroy, F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 149, 73–80 (2011).
Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J. & de los Reyes-Gavilan, C. G. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 362 (2015).
Ruiz-Ojeda, F. J., Plaza-Diaz, J., Saez-Lara, M. J. & Gil, A. Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials. Adv Nutr 10, S31–S48 (2019).
Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181–186 (2014).
Rodriguez-Palacios, A. et al. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease-Like Ileitis. Inflamm Bowel Dis 24, 1005–1020 (2018).
Zoetendal, E. G. et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 6, 1415–1426 (2012).
Neis, E. P. et al. Distal versus proximal intestinal short-chain fatty acid release in man. Gut 68, 764–765 (2019).
Wan Saudi, W. S. & Sjoblom, M. Short-chain fatty acids augment rat duodenal mucosal barrier function. Exp Physiol 102, 791–803 (2017).
Akiba, Y. et al. Short-chain fatty acid sensing in rat duodenum. J Physiol 593, 585–599 (2015).
Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543–547 (2011).
Silveira, A. L. M. et al. Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice. Eur J Nutr 56, 179–191 (2017).
Masui, R. et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis 19, 2848–2856 (2013).
Becker, F. et al. A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis. Inflamm Bowel Dis 22, 1326–1345 (2016).
Murray, P. J. Macrophage Polarization. Annu Rev Physiol 79, 541–566 (2017).
Bain, C. C. & Mowat, A. M. Macrophages in intestinal homeostasis and inflammation. Immunol Rev 260, 102–117 (2014).
Canadian Institutes for Health Research; Alberta Innovates; Canadian Association of Gastroenterology.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.